These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ribozymes in the age of molecular therapeutics. Bagheri S; Kashani-Sabet M Curr Mol Med; 2004 Aug; 4(5):489-506. PubMed ID: 15267221 [TBL] [Abstract][Full Text] [Related]
4. Synthetic hammerhead ribozymes as therapeutic tools to control disease genes. Citti L; Rainaldi G Curr Gene Ther; 2005 Feb; 5(1):11-24. PubMed ID: 15638708 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic applications of group I intron-based trans-splicing ribozymes. Lee CH; Han SR; Lee SW Wiley Interdiscip Rev RNA; 2018 May; 9(3):e1466. PubMed ID: 29383855 [TBL] [Abstract][Full Text] [Related]
12. Nucleic acid enzymes as a novel generation of anti-gene agents. Sioud M Curr Mol Med; 2001 Nov; 1(5):575-88. PubMed ID: 11899232 [TBL] [Abstract][Full Text] [Related]
13. Application of preformed hammerhead ribozymes in the gene therapy of cancer (review). Sioud M Int J Mol Med; 1999 Apr; 3(4):381-4. PubMed ID: 10085409 [TBL] [Abstract][Full Text] [Related]
14. Group I Intron-Based Therapeutics Through Trans-Splicing Reaction. Lee CH; Han SR; Lee SW Prog Mol Biol Transl Sci; 2018; 159():79-100. PubMed ID: 30340790 [TBL] [Abstract][Full Text] [Related]
15. HIV and Ribozymes. Scarborough RJ; Gatignol A Adv Exp Med Biol; 2015; 848():97-116. PubMed ID: 25757617 [TBL] [Abstract][Full Text] [Related]
16. Ribozymes: a modern tool in medicine. Khan AU; Lal SK J Biomed Sci; 2003; 10(5):457-67. PubMed ID: 12928586 [TBL] [Abstract][Full Text] [Related]
17. Hammerhead ribozymes targeted to the FBN1 mRNA can discriminate a single base mismatch between ribozyme and target. Phylactou LA; Tsipouras P; Kilpatrick MW Biochem Biophys Res Commun; 1998 Aug; 249(3):804-10. PubMed ID: 9731217 [TBL] [Abstract][Full Text] [Related]
18. Hammerhead ribozymes as therapeutic agents for bladder cancer. Irie A; Kashani-Sabet M; Scanlon KJ; Uchida T; Baba S Mol Urol; 2000; 4(2):61-6. PubMed ID: 12006244 [TBL] [Abstract][Full Text] [Related]
19. A cellular high-throughput screening approach for therapeutic trans-cleaving ribozymes and RNAi against arbitrary mRNA disease targets. Yau EH; Butler MC; Sullivan JM Exp Eye Res; 2016 Oct; 151():236-55. PubMed ID: 27233447 [TBL] [Abstract][Full Text] [Related]
20. The hairpin ribozyme: discovery, two-dimensional model, and development for gene therapy. Hampel A Prog Nucleic Acid Res Mol Biol; 1998; 58():1-39. PubMed ID: 9308362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]